Deigner HP[Author] - Search Results

Year	Number of Results
1988	3
1990	1
1992	2
1993	1
1994	1
1995	4
1996	2
1997	4
1998	2
1999	4
2000	3
2001	2
2002	1
2003	3
2004	1
2005	6
2006	3
2007	1
2008	1
2009	5
2010	8
2011	2
2012	4
2013	1
2015	2
2016	4
2017	2
2018	2
2019	7
2020	9
2021	14
2022	0

1

Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.

Hoenke S, Serbian I, Deigner HP, Csuk R. Hoenke S, et al. Among authors: deigner hp. Molecules. 2020 Nov 20;25(22):5443. doi: 10.3390/molecules25225443. Molecules. 2020. PMID: 33233650 Free PMC article. Review.

2

Bimodal imaging and beyond.

Deigner HP. Deigner HP. Atherosclerosis. 2016 Nov;254:307-308. doi: 10.1016/j.atherosclerosis.2016.10.015. Epub 2016 Oct 8. Atherosclerosis. 2016. PMID: 27743601 No abstract available.

3

Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance.

Rentschler S, Kaiser L, Deigner HP. Rentschler S, et al. Among authors: deigner hp. Int J Mol Sci. 2021 Jan 5;22(1):456. doi: 10.3390/ijms22010456. Int J Mol Sci. 2021. PMID: 33466437 Free PMC article. Review.

4

The potential of click reactions for the synthesis of bioactive triterpenes.

Csuk R, Deigner HP. Csuk R, et al. Among authors: deigner hp. Bioorg Med Chem Lett. 2019 Apr 15;29(8):949-958. doi: 10.1016/j.bmcl.2019.02.020. Epub 2019 Feb 19. Bioorg Med Chem Lett. 2019. PMID: 30799214 Review.

5

Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.

Khan AA, Manzoor KN, Sultan A, Saeed M, Rafique M, Noushad S, Talib A, Rentschler S, Deigner HP. Khan AA, et al. Among authors: deigner hp. Int J Mol Sci. 2021 Jan 16;22(2):859. doi: 10.3390/ijms22020859. Int J Mol Sci. 2021. PMID: 33467089 Free PMC article. Review.

6

Targeted metabolomics for biomarker discovery.

Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP. Griffiths WJ, et al. Among authors: deigner hp. Angew Chem Int Ed Engl. 2010 Jul 26;49(32):5426-45. doi: 10.1002/anie.200905579. Angew Chem Int Ed Engl. 2010. PMID: 20629054 Review.

7

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.

Blaess M, Kaiser L, Sauer M, Csuk R, Deigner HP. Blaess M, et al. Among authors: deigner hp. Int J Mol Sci. 2020 Jul 13;21(14):4953. doi: 10.3390/ijms21144953. Int J Mol Sci. 2020. PMID: 32668803 Free PMC article. Review.

8

The molecular sepsis signature.

Deigner HP, Kohl M. Deigner HP, et al. Crit Care Med. 2009 Mar;37(3):1137-8. doi: 10.1097/CCM.0b013e31819bb705. Crit Care Med. 2009. PMID: 19237934 No abstract available.

9

Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine.

Gülbakan B, Özgül RK, Yüzbaşıoğlu A, Kohl M, Deigner HP, Özgüç M. Gülbakan B, et al. Among authors: deigner hp. EPMA J. 2016 Dec 8;7(1):24. doi: 10.1186/s13167-016-0074-2. eCollection 2016. EPMA J. 2016. PMID: 27980697 Free PMC article. Review.

10

Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy.

Blaess M, Deigner HP. Blaess M, et al. Among authors: deigner hp. Int J Mol Sci. 2019 Aug 15;20(16):3967. doi: 10.3390/ijms20163967. Int J Mol Sci. 2019. PMID: 31443157 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results